Nexalin Technology
12 hedge funds and large institutions have $467K invested in Nexalin Technology in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
425% more capital invested
Capital invested by funds: $88.9K → $467K (+$378K)
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
140% more funds holding
Funds holding: 5 → 12 (+7)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
2.79% more ownership
Funds ownership: 0.85% → 3.64% (+2.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$88K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$81.6K |
| 3 |
AWS
Atria Wealth Solutions
New York
|
+$56.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.7K |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$15.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$176 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$62 |
NXL Hedge Fund Activity: Q2 2024 in Review
12 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q2 2024, worth a combined $467K — up 425% from $88.9K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NXL positions and 2 closed out — a net gain of 7 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $88K. The largest seller was Jane Street, exiting entirely with an estimated $15.8K sold.
- 12 institutional investors held Nexalin Technology (NXL) as of Q2 2024, up from 5 in Q1 2024.
- Funds reported $467K of Nexalin Technology stock for Q2 2024, up 425% quarter-over-quarter.
- 9 funds opened new Nexalin Technology positions in Q2 2024 and 2 closed out, a net change of +7 holders.
- The largest Nexalin Technology buyer in Q2 2024 was Morgan Stanley, an estimated $88K added.
- The largest Nexalin Technology seller in Q2 2024 was Jane Street, an estimated $15.8K sold.
Based on aggregated 13F filings for Q2 2024.